Phase II Vanguards

The eyesON Phase II Vanguards provides comprehensive oversight of groundbreaking investigational new drugs and under-the-radar institutions developing them

Phase II VanguardsPhase II Vanguards is an interactive data visualization tool providing a comprehensive oversight of the dynamic world of Phase II clinical trials spearheaded by small pharma companies and research innovators. Explore a wealth of information from geographical distribution, disease focus, drug development progress, to study statuses, and unlock valuable insights into the pioneering forces driving breakthroughs in healthcare.

This interactive data visualization tool has been designed as a panoramic snapshot of the landscape of Phase II clinical studies. Recognized as the most critical and uncertain stage in drug development, Phase II trials serve as a gateway between early stage exploration and the final push towards regulatory approval. Compounds that demonstrate promise during this stage have a higher likelihood of ultimately reaching the market. This tool is envisioned to be a convenient resource for larger pharmaceutical companies interested in identifying potential acquisition targets among these promising Phase II trials.

What are Vanguard companies?

Vanguard Companies, as referred to within this application, encompass all companies, research organizations, and institutions that are conducting Phase II clinical studies. These entities are distinct in that they are not affiliated with or owned by the 100 largest pharmaceutical companies, and they are reported in the database.


The basis for the Phase II Vanguards clinical data visualization tool is the data collected from database between 2021 and 2023, ensuring up-to-date clinical trial trends information.

Detailed information about the data used, methods of data extraction and scientific methods used in the analysis, you can find in the Data Definition tab of the app.

eyesON series

Phase II Vanguards Clinical Trial Data Visualizer is just one of the visualizers in Cyntegrity’s eyesON series of interactive data visualizers. We envision this series as a way our company can give back to the clinical research community. By utilizing our data processing skills and clinical research expertise, we try to come up with useful data visualization tool that our industry peers can freely use to conveniently access the clinical industry insights.

Interested in other Cyntegrity interactive data visualizers? Check them out here.

Our Commitment to Innovation and Personal Growth

We are dedicated to providing innovative solutions that help our clients make the most of their data. One of our latest offerings is the Cyntegrity eyesON apps, which provide visual aids to help users efficiently and effectively understand the significance of data. The development of these apps brings cross-functional team members together, and it serves as an exercise to challenge our internal talents and drive personal growth.

We believe in continuous improvement, and commit to fostering an environment where our team members can develop new skills and grow both professionally and personally. These projects are a crucial part of our strategy for investing in our human capital, and we are proud of the results we have achieved so far.